A Multicentre, Double-Blind, Placebo-Controlled, Adaptive Pivotal Study of the Efficacy and Safety of Oral BC1036 in the Management of Cough
The purpose of this study is to investigate the effect of BC1036 (theobromine) on cough-related quality of life and cough severity following 2 weeks' treatment.
A Multicentre, Double-Blind, Placebo-Controlled, Adaptive Pivotal Study of the Efficacy and Safety of Oral BC1036 in the Management of Cough
100 Clinical Results associated with Respicopea, Inc.
0 Patents (Medical) associated with Respicopea, Inc.
100 Deals associated with Respicopea, Inc.
100 Translational Medicine associated with Respicopea, Inc.